validating surrogate endpoints in oncology
Published 4 years ago • 213 plays • Length 1:16:27Download video MP4
Download video MP3
Similar videos
-
18:40
use of surrogate endpoints in oncology
-
11:11
lecture medical oncology - endpoints in clinical trials
-
41:00
surrogate endpoints – overcoming reimbursement and validation challenges
-
11:58
statistical considerations on the use of surrogate endpoints | thomas fleming
-
3:45
endpoints, clinical trial outcomes, & surrogate endpoints
-
2:13
choosing cancer clinical trial endpoints
-
2:20
biomarkers and surrogate endpoints in drug development
-
1:03:46
surrogate endpoints in solid and liquid tumors
-
3:38
surrogate markers
-
17:28
oncology clinical trials: an emerging paradigm shift in trial design
-
19:23
clinical endpoints and outcomes |clinical trials and data management|
-
3:29
assessing intermediate clinical endpoints as potential surrogates for os in prostate cancer
-
24:46
the value of surrogate endpoints in the benefit-risk assessment of new drugs | gabe sonke, md, phd
-
1:26
surrogate endpoints in clinical trials i clinical research
-
9:24
segment 5 - surrogate end points in clinical trials: the right information?
-
2:17
oncology clinical trials: why we're searching for emerging endpoints
-
3:07
use of surrogate endpoints a case study
-
2:56
surrogate outcomes
-
2:08
surrogate endpoints acceptance in hta
-
1:00
what are the surrogate endpoints in aml?
-
3:58
surrogate endpoints for new drug discovery in acute lymphoblastic leukemia
-
5:47
surrogate endpoint biomarkers in research